Cullinan Oncology LLC (CGEM) — Cash Flow Quality Index
Cullinan Oncology LLC (CGEM) has a Cash Flow Quality Index of -0.15x as of June 2022. Operating cash flow of $-25.42 Million is below net income of $174.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Cullinan Oncology LLC (CGEM) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cullinan Oncology LLC Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Cullinan Oncology LLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see CGEM operating cash flow.
Annual Cash Flow Quality Index for Cullinan Oncology LLC (2022–2022)
Year-by-year earnings quality comparison for Cullinan Oncology LLC.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.16x | $-126.66 Million | $109.19 Million | — |